Thomson Reuters Westlaw Publishes Akin Gump Article on International Trade MedTech Trends to Watch
Contact:
Thomson Reuters Westlaw has published the article “Legal and regulatory issues to watch for in the medical technology industry: International trade — customs, export controls, sanctions, CFIUS and trade policy,” written by Akin Gump international trade partners Anne Borkovic, Stephen Kho and Nnedinma Ifudu Nweke and counsel Emily Fuller Opp.
Adapted from a lengthier Akin Gump client alert, the article looks at some of the significant changes—legal, regulatory and market—that could have “a lasting impact” on medical device and diagnostics companies and laboratories with regard to international trade. They include:
- An expansion of Section 301 customs duties, with the possibility for more.
- Heightened scrutiny on health data-related transactions involving foreign persons.
- Export controls on encryption and telecommunications that could affect the MedTech industry.
To read the article in its entirety, please click here.
People Mentioned in This News
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.